Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedU.S. GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
No applicable matters. The notes on the going concern assumption state that there are no applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | U.S. GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥1,093,653 million (YoY +3.3%) |
| Operating profit | ¥71,370 million (YoY -26.1%) |
| Profit attributable to owners of the parent | ¥48,303 million (YoY -33.1%) |
| Net income per share | ¥55.20 |
| Equity ratio | End of the current fiscal period 55 / End of previous period 56.9 |
| Total assets | ¥6,237,861 million |
| Net assets | ¥3,660,204 million |
| Cash flows from operating activities | ¥24,509 million |
| Cash flows from investing activities | ¥-57,389 million |
| Cash flows from financing activities | ¥84,044 million |
| Cash and cash equivalents at end of period | ¥639,490 million |
| Full-year earnings forecast | Net Sales ¥4,765,000 million (YoY +3.0%) / Operating profit ¥456,000 million (YoY +0.1%) / Ordinary income ¥483,000 million (YoY +0.2%) / Net income ¥333,000 million (YoY +0.3%) |
| Annual Dividend Forecast | ¥160 → ¥160(0.0%) |
| Payout ratio | 40% |
| Shareholder Return Policy | Stable and proactive shareholder returns, targeting a payout ratio of 40% without reducing dividends |
| Segment revenue | Printing ¥610,504 million (YoY -0.1%), Medical ¥142,067 million (YoY +3.4%), Imaging ¥245,886 million (YoY +15.9%), Industrial ¥66,965 million (YoY -0.7%), Other and Corporate ¥53,884 million (YoY -3.8%) |
| Segment profit | Printing ¥59,873 million (YoY -18.0%), Medical ¥5,215 million (YoY -22.2%), Imaging ¥27,767 million (YoY -11.1%), Industrial ¥4,811 million (YoY -42.6%), Other and Corporate ¥-25,559 million, Eliminations ¥-737 million |
| Regional sales | ¥239,581 million (YoY +0.1%), ¥854,072 million (YoY +4.3%), ¥340,965 million (YoY +1.2%), ¥290,741 million (YoY +6.5%), ¥222,366 million (YoY +6.3%) |
| Depreciation and amortization | ¥56,200 million |
| Disclosure regarding the going concern assumption | No applicable matters. The notes on the going concern assumption state that there are no applicable matters. |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate Yes / Restatement Not disclosed |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Not disclosed |
| Issued Shares at Period-End | 1,333,763,464 |
| Treasury Shares at Period-End | 465,175,943 |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The interim review by the audit firm of the quarterly consolidated financial statements has been completed. The company states that there are no changes to the quarterly consolidated financial statements announced on 23 April.